ScreenerHero
SHLSiemens Healthineers AG
XETRA · DE · Healthcare · Medical Devices · siemens-healthineers.com
40.20EUR+0.98%Mkt Cap: 48.43B $P/E: 19.91

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS,…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$198.81BUSDP/E 36.9
SYK
STRYKER CORP. R
$120.66BUSDP/E 34.7
SYK
Stryker Corporation
$125.70BUSDP/E 33.9
2M6
Medtronic plc
$111.66BUSDP/E 24.9
BSX
Boston Scientific Corporation
$75.37BUSDP/E 21.1
EW
Edwards Lifesciences Corporation
$53.13BUSDP/E 54.9
GEHC
GE HealthCare Technologies Inc. Common Stock
$33.94BUSDP/E 17.2
DXCM
DexCom, Inc.
$33.92BUSDP/E 35.5
PHIA
Koninklijke Philips N.V.
$25.21BUSDP/E 20.8
ZBH
Zimmer Biomet Holdings, Inc.
$19.21BUSDP/E 24.5
SOON
Sonova Holding AG
$16.48BUSDP/E 26.9
PEN
Penumbra, Inc.
$12.87BUSDP/E 80.5
SN
Smith & Nephew plc
$11.52BUSDP/E 19.9
GMED
Globus Medical, Inc.
$11.86BUSDP/E 22.6
GKOS
Glaukos Corp
$11.18BUSD
EUZ
Eckert & Ziegler Strahlen-und Medizinte AG
$9.89BUSDP/E 16.8
PODD
Insulet Corporation
$10.51BUSDP/E 28.4
BIO
Bio-Rad Laboratories, Inc. Class A
$9.75BUSDP/E 44.3
MASI
Masimo Corporation
$9.42BUSDP/E 44.4
DEMANT
Demant A/S
$8.77BUSDP/E 24.9

Key Statistics

Company
Market Cap48.43B $
Enterprise Value61.63B $
Revenue (TTM)25.18B $
Gross Profit9.83B $
Net Income (TTM)2.41B $
Revenue/Share22.47 USD
Last Price40.20 EUR
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees74.3K
CountryDE
SectorHealthcare
IndustryMedical Devices
ISINUS82622J1043
Valuation
P/E (Trailing)19.91
P/E (Forward)16.75
PEG1.73
EV/EBITDA14.10
EV/Revenue2.45
P/S1.91
P/B2.31
EPS (TTM)1.97
EPS (Forward)2.36
52W Range
32.8144% of range49.71
52W High49.71 EUR
52W Low32.81 EUR
Profitability
Gross Margin39.02%
Oper. Margin16.41%
EBITDA Margin17.36%
Profit Margin9.55%
ROE12.15%
ROA4.48%
Growth
Revenue Growth1.80%
Earnings Growth22.40%
Cash Flow & Leverage
Operating CF3.72B $
CapEx (TTM)—
FCF Margin9.26%
FCF Yield4.82%
Net Debt13.74B $
Net Debt/EBITDA3.14
Balance Sheet
Debt/Equity78.30
Current Ratio1.16
Quick Ratio0.70
Book Value/Sh17.13 EUR
Cash/Share2.117 EUR
Dividends
Fwd Div Rate1.000 EUR
Trail. Div Rate1.000 EUR
Div. Yield2.53%
5Y Avg Yield1.84%
Payout Ratio50.76%
Ex-Div DateFeb 6, 2026
Pay Date—
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)45.05 EUR
Upside (mean)+12.1%
Target Range36.00 EUR – 57.40 EUR
€36.00+12.1% to mean€57.40
# Analysts20
Ownership
Shares Out.1.12B
Float357.71M
Insiders67.02%
Institutions14.87%
Technical
SMA 5035.95 (+11.8%)
SMA 20038.97 (+3.1%)
Beta0.83
S&P 52W Chg20.26%
Avg Vol (30d)981.90K
Avg Vol (10d)726.85K
Technical Indicators
RSI (14)68.0
MACD1.1984
MACD Signal1.1241
MACD Hist.+0.0743
BB Upper41.88 EUR
BB Middle37.97 EUR
BB Lower34.06 EUR
BB Width20.60%
ATR (14)0.8915 EUR
Vol Ratio (20d)0.58x